The incidence of Human Papillomavirus (HPV)–associated oropharyngeal cancers—tumors of the back of the mouth and throat—is rising. If caught early, most of these cancers have a high survival ...

How might proteomics-based approaches be utilized for unraveling the complex interplay between HPV infection and protein dysfunction that ultimately results in cervical cancer?

Kronos Bio (KRON) announced preclinical data from its p300 KAT inhibitor program for human papillomavirus-driven tumors at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.